GlassScriptPhysician profile
Amanda M Rogers
NPI 1104347244
$427.52
in general payments reported to CMS, 2019-2025
8 companies · $232 in 2025
The $232 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $43.31 · 2023: $68.37 · 2024: $83.43 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $384.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $188.81 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $123.27 | 2022-2025 | |
| Evofem Biosciences, INC. | $34.00 | 2024-2025 | Solosec, Phexx, Phexxi |
| Sage Therapeutics, LLC | $18.86 | 2024 | |
| Agile Therapeutics, INC. | $17.00 | 2023 | Twirla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.76 | 2025 | Xifaxan |
| Abbvie INC. | $15.99 | 2023 | |
| Avion Pharmaceuticals | $12.83 | 2023 | Balcoltra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.